RIG
44
-2
PG
50
2
MAT
38
-3
KO
44
2
FRT
48
2
AON
60
2
PAYX
57
-2
NRG
50
-2
LEN
52
2
DVA
72
-3
ADI
45
-5
COF
63
-4
SIG
47
-2
RSG
77
4
KEY
46
-2
CI
52
-7
REGN
42
-2
IVZ
49
-3
ETR
68
-3
RCL
88
-2
RIG
44
-2
PG
50
2
MAT
38
-3
KO
44
2
FRT
48
2
AON
60
2
PAYX
57
-2
NRG
50
-2
LEN
52
2
DVA
72
-3
ADI
45
-5
COF
63
-4
SIG
47
-2
RSG
77
4
KEY
46
-2
CI
52
-7
REGN
42
-2
IVZ
49
-3
ETR
68
-3
RCL
88
-2
Financhill
Back

Protagonist Therapeutics Vs. Affirm Holdings Industry Stock Comparison

Sell
32

PTGX
Protagonist Therapeutics

Last Price:
41.40
Seasonality Move:
12.96%
Buy
53

AFRM
Affirm Holdings

Last Price:
53.33
Seasonality Move:
1.82%
Sell
32
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $42.67. The Score for PTGX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Affirm Holdings (AFRM) is a Buy

Is Affirm Holdings a Buy, Sell or Hold?

  • The current Affirm Holdings [AFRM] share price is $54.83. The Score for AFRM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • AFRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $42.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.

AFRM Stock Price Chart

What is Affirm Holdings's stock price today?

  • The Affirm Holdings share price today is $54.83
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AFRM is experiencing selling pressure, which indicates risk of future bearish movement.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 35.81 Sell
Chaikin Money Flow: -366275 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.81 - 47.77) Sell
Bollinger Bands (100): (37.08 - 46.34) Buy

AFRM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.17 Buy
Relative Strength Index (14 RSI): 64.86 Buy
Chaikin Money Flow: -8031727 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.65 - 50.83) Buy
Bollinger Bands (100): (28.5 - 44.96) Buy

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.8 Sell
20-day SMA: 46.52 Sell
50-day SMA: 45.56 Sell
200-day SMA: 35.25 Buy
8-day EMA: 45.25 Sell
20-day EMA: 45.9 Sell
50-day EMA: 44.83 Sell
200-day EMA: 36.55 Buy

AFRM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.57 Buy
20-day SMA: 46.33 Buy
50-day SMA: 43.79 Buy
200-day SMA: 35.8 Buy
8-day EMA: 51.59 Buy
20-day EMA: 47.76 Buy
50-day EMA: 43.48 Buy
200-day EMA: 36.08 Buy

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.95 per share.

Affirm Holdings Earnings Growth & AFRM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $1.43 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Affirm Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):